Skip to main content
رجوع
PMCUF logo

Pro Medicus Limited

جودة البيانات: 100%
PMCUF
OTC Healthcare Medical - Healthcare Information Services
KWD 85.66
▼ KWD 2.55 (-2.89%)
القيمة السوقية: 8.95B
نطاق اليوم
KWD 82.00 KWD 85.66
نطاق 52 أسبوعًا
KWD 74.52 KWD 218.25
حجم التداول
211
متوسط 50 يوم / 200 يوم
KWD 105.68 / KWD 163.67
الإغلاق السابق
KWD 88.21

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E 77.7 0.4
P/B 34.8 2.9
ROE % 51.8 3.8
Net Margin % 54.1 3.9
Rev Growth 5Y % 33.1 10.0
D/E 0.0 0.2

السعر المستهدف للمحللين

Hold
KWD 155.000 +80.9%
مكرر الربحية المستقبلي
49.5
ربحية السهم المستقبلية
KWD 1.732
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
290 M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 0.000
KWD 0.000 – KWD 0.000
540 M 0
FY2029 KWD 3.623
KWD 3.315 – KWD 3.901
600 M 1
FY2028 KWD 2.487
KWD 2.276 – KWD 2.678
470 M 1

النقاط الرئيسية

Revenue grew 33.08% annually over 5 years — strong growth
Earnings grew 39.16% over the past year
ROE of 51.82% indicates high profitability
Net margin of 54.12% shows strong profitability
Debt/Equity of 0.01 — conservative balance sheet
Generating 103.96M in free cash flow

النمو

Revenue Growth (5Y)
33.08%
Revenue (1Y)31.83%
Earnings (1Y)39.16%
FCF Growth (3Y)33.50%

الجودة

Return on Equity
51.82%
ROIC45.60%
Net Margin54.12%
Op. Margin74.03%

الأمان

Debt / Equity
0.01
Current Ratio6.49
Interest Coverage0.00

التقييم

P/E Ratio
77.67
P/B Ratio34.83
EV/EBITDA55.68
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 31.83% Revenue Growth (3Y) 30.56%
Earnings Growth (1Y) 39.16% Earnings Growth (3Y) 37.83%
Revenue Growth (5Y) 33.08% Earnings Growth (5Y) 39.02%
Profitability
Revenue (TTM) 212.91M Net Income (TTM) 115.22M
ROE 51.82% ROA 34.02%
Gross Margin 99.85% Operating Margin 74.03%
Net Margin 54.12% Free Cash Flow (TTM) 103.96M
ROIC 45.60% FCF Growth (3Y) 33.50%
Safety
Debt / Equity 0.01 Current Ratio 6.49
Interest Coverage 0.00 Dividend Yield 0.00%
Valuation
P/E Ratio 77.67 P/B Ratio 34.83
P/S Ratio 42.03 PEG Ratio 6.50
EV/EBITDA 55.68 Dividend Yield 0.00%
Market Cap 8.95B Enterprise Value 8.78B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 212.91M 161.50M 124.90M 93.46M 67.88M
Net Income 115.22M 82.79M 60.65M 44.44M 30.85M
EPS (Diluted) 1.10 0.79 0.58 0.43 0.30
Gross Profit 212.60M 161.20M 92.37M 92.94M 46.66M
Operating Income 157.61M 114.84M 86.20M 64.93M 44.42M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 338.70M 257.43M 202.14M 157.05M 125.57M
Total Liabilities 81.74M 69.70M 63.36M 55.32M 43.89M
Shareholders' Equity 256.96M 187.73M 138.78M 101.73M 81.68M
Total Debt 2.26M 2.07M 1.85M 2.28M 2.62M
Cash & Equivalents 174.54M 60.06M 91.25M 63.66M 42.04M
Current Assets 280.09M 206.56M 163.79M 119.82M 87.57M
Current Liabilities 43.14M 34.56M 30.85M 26.86M 17.62M

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#46 of 154
71

النشاط الأخير

دخل Growth Investing (Philip Fisher)
Mar 24, 2026